Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies

Overview

Journal JACC Basic Transl Sci

Date 2021 Aug 9

PMID 34368511

Citations 35

Authors

Thorsten Kessler

Heribert Schunkert

Affiliations

Soon will be listed here.

Abstract

Many cardiovascular diseases are facilitated by strong inheritance. For example, large-scale genetic studies identified hundreds of genomic loci that affect the risk of coronary artery disease. At each of these loci, common variants are associated with disease risk with robust statistical evidence but individually small effect sizes. Only a minority of candidate genes found at these loci are involved in the pathophysiology of traditional risk factors, but experimental research is making progress in identifying novel, and, in part, unexpected mechanisms. Targets identified by genome-wide association studies have already led to the development of novel treatments, specifically in lipid metabolism. This review summarizes recent genetic and experimental findings in this field. In addition, the development and possible clinical usefulness of polygenic risk scores in risk prediction and individualization of treatment, particularly in lipid metabolism, are discussed.

Citing Articles

Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications.

Lee H, Fernandes M, Lee J, Merino J, Kwak S Diabetologia. 2025; .

PMID: 40088285 DOI: 10.1007/s00125-025-06403-9.

Chronic Coronary Artery Disease: Wall Disease vs. Lumenopathy.

Paraskevaidis I, Kourek C, Tsougos E Biomolecules. 2025; 15(2).

PMID: 40001504 PMC: 11852618. DOI: 10.3390/biom15020201.

Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome-An Update.

Elfaki I, Mir R, Elnageeb M, Hamadi A, Alharbi Z, Bedaiwi R Medicina (Kaunas). 2025; 61(1).

PMID: 39859066 PMC: 11767019. DOI: 10.3390/medicina61010083.

Smoking-Associated Changes in Gene Expression in Coronary Artery Disease Patients Using Matched Samples.

Merzah M, Poliska S, Balogh L, Sandor J, Fiatal S Curr Issues Mol Biol. 2024; 46(12):13893-13902.

PMID: 39727958 PMC: 11727024. DOI: 10.3390/cimb46120830.

Influence of Common Gene Variants on Lipid Levels and Risk of Coronary Heart Disease in Afro-Caribbeans.

Larifla L, Bassien-Capsa V, Velayoudom F, Chingan-Martino V, Afassinou Y, Ancedy Y Int J Mol Sci. 2024; 25(20).

PMID: 39456920 PMC: 11508861. DOI: 10.3390/ijms252011140.

References

Bennett B, Davis R, Civelek M, Orozco L, Wu J, Qi H . Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains. PLoS Genet. 2015; 11(12):e1005711. PMC: 4687930. DOI: 10.1371/journal.pgen.1005711. View

Mega J, Stitziel N, Smith J, Chasman D, Caulfield M, Devlin J . Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015; 385(9984):2264-2271. PMC: 4608367. DOI: 10.1016/S0140-6736(14)61730-X. View

McKeown P, Merlini P, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M . Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009; 41(3):334-41. PMC: 2681011. DOI: 10.1038/ng.327. View

Yu R, Gunawan R, Post N, Zanardi T, Hall S, Burkey J . Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys. Nucleic Acid Ther. 2016; 26(6):372-380. DOI: 10.1089/nat.2016.0623. View

Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes T, Thompson J . Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2012; 45(1):25-33. PMC: 3679547. DOI: 10.1038/ng.2480. View

Hollands G, French D, Griffin S, Prevost A, Sutton S, King S . The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016; 352:i1102. PMC: 4793156. DOI: 10.1136/bmj.i1102. View

Viola J, Lemnitzer P, Paulin N, Drechsler M, Nazari-Jahantigh M, Maas S . Deletion of MFGE8 Inhibits Neointima Formation upon Arterial Damage. Thromb Haemost. 2018; 118(7):1340-1342. DOI: 10.1055/s-0038-1649522. View

Chatterjee N, Shi J, Garcia-Closas M . Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet. 2016; 17(7):392-406. PMC: 6021129. DOI: 10.1038/nrg.2016.27. View

Stitziel N, Stirrups K, Masca N, Erdmann J, Ferrario P, Konig I . Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med. 2016; 374(12):1134-44. PMC: 4850838. DOI: 10.1056/NEJMoa1507652. View

10.

Lavine K, Long F, Choi K, Smith C, Ornitz D . Hedgehog signaling to distinct cell types differentially regulates coronary artery and vein development. Development. 2008; 135(18):3161-71. PMC: 4306353. DOI: 10.1242/dev.019919. View

11.

Aherrahrou R, Aherrahrou Z, Schunkert H, Erdmann J . Coronary artery disease associated gene Phactr1 modulates severity of vascular calcification in vitro. Biochem Biophys Res Commun. 2017; 491(2):396-402. DOI: 10.1016/j.bbrc.2017.07.090. View

12.

Braenne I, Civelek M, Vilne B, Di Narzo A, Johnson A, Zhao Y . Prediction of Causal Candidate Genes in Coronary Artery Disease Loci. Arterioscler Thromb Vasc Biol. 2015; 35(10):2207-17. PMC: 4583353. DOI: 10.1161/ATVBAHA.115.306108. View

13.

Holdt L, Teupser D . Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol. 2012; 32(2):196-206. DOI: 10.1161/ATVBAHA.111.232678. View

14.

Cambien F, Poirier O, Lecerf L, Evans A, Cambou J, Arveiler D . Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359(6396):641-4. DOI: 10.1038/359641a0. View

15.

Marston N, Kamanu F, Nordio F, Gurmu Y, Roselli C, Sever P . Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial. Circulation. 2019; 141(8):616-623. PMC: 8058781. DOI: 10.1161/CIRCULATIONAHA.119.043805. View

16.

Bauer R, Tohyama J, Cui J, Cheng L, Yang J, Zhang X . Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice. Circulation. 2015; 131(13):1202-1213. PMC: 4382454. DOI: 10.1161/CIRCULATIONAHA.114.012669. View

17.

Erdmann J, Kessler T, Venegas L, Schunkert H . A decade of genome-wide association studies for coronary artery disease: the challenges ahead. Cardiovasc Res. 2018; 114(9):1241-1257. DOI: 10.1093/cvr/cvy084. View

18.

Sabatine M, Giugliano R, Wiviott S, Raal F, Blom D, Robinson J . Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015; 372(16):1500-9. DOI: 10.1056/NEJMoa1500858. View

19.

Wirka R, Wagh D, Paik D, Pjanic M, Nguyen T, Miller C . Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med. 2019; 25(8):1280-1289. PMC: 7274198. DOI: 10.1038/s41591-019-0512-5. View

20.

Reilly M, Li M, He J, Ferguson J, Stylianou I, Mehta N . Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011; 377(9763):383-92. PMC: 3297116. DOI: 10.1016/S0140-6736(10)61996-4. View